PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2020-05-28

Date Title Company
28-May-2020 Laboratory relocation specialist backs NHS tribute Aport
28-May-2020 Pivotal Preclinical Oncology Platform Expands to Include New Patient-Derived Organoid Models Hubrecht Organoid Technology
28-May-2020 New gut health and immunity white paper launched Clasado Biosciences
28-May-2020 Pneumagen Announces £4m Fundraising and Commits to Clinical Trial Development for COVID-19 Pneumagen
28-May-2020 Cytovation Announces Dosing of First Patient in its Phase I/II CICILIA Trial Investigating CyPep-1 in Patients with Solid Cancers Cytovation AS
28-May-2020 Sanofi announces pricing of Regeneron stock offering Sanofi
28-May-2020 NuCana to Present at the 2020 Jefferies Virtual Healthcare Conference NuCana plc
28-May-2020 Oxitec’s New Friendly Aedes aegypti Mosquito Technology Receives Full Biosafety Approval in Brazil Oxitec Ltd
28-May-2020 Cidara Therapeutics Doses First Patient in Pivotal Phase 3 ReSPECT Trial of Rezafungin for Prevention of Invasive Fungal Disease in Patients Undergoing Allogeneic Blood and Marrow Transplantation Cidara Therapeutics, Inc
28-May-2020 Synairgen Completes Recruitment of Hospitalised Patients in COVID-19 Trial Synairgen plc
28-May-2020 Faron announces R&D Day to be held in June Faron Pharmaceuticals
28-May-2020 IRBM’s Advent announces manufacture of 13,000 doses of Covid-19 vaccine, for use in Phase 2/3 clinical trials by the University of Oxford IRBM Group
28-May-2020 Akcea and Ionis Announce Publication of Long-Term Clinical Data of TEGSEDI® in Patients with Polyneuropathy Driven by Hereditary Transthyretin Amyloidosis Demonstrating Sustained Improvements and Even Greater Stabilization in Patients Starting Earlier Treatment Akcea Therapeutics, Inc
28-May-2020 Evelo Biosciences to Present at Jefferies Virtual Healthcare Conference Evelo Biosciences
28-May-2020 Oxford Biomedica Signs Clinical & Commercial Supply Agreement with AstraZeneca, for manufacture of COVID-19 vaccine candidate Oxford Biomedica plc
28-May-2020 Ashvattha Therapeutics Subsidiary Orpheris Announces FDA Agreement to Initiate Phase 2 Study Evaluating OP-101 in Severe COVID-19 Patients Ashvattha Therapeutics
28-May-2020 Almac Group Supports Two COVID-19 Clinical Studies in Sub-Saharan Africa Almac Group
28-May-2020 Shinshu University and Toshiba Develop Tumor-Tropic Liposome Technology that Carries Therapeutic Genes into Cancer Cells Toshiba Corporation
28-May-2020 Vetter Wins Axia Best Managed Companies Award B3C newswire
28-May-2020 Orphan Reach Expedites Phase II COVID-19 Study With TransPerfect's Trial Interactive eTMF And Remote Monitoring Solution TransPerfect